Literature DB >> 18707828

Truths and myths about radiotherapy for verrucous carcinoma of larynx.

Shao Hui Huang1, Gina Lockwood, Jonathan Irish, Jolie Ringash, Bernard Cummings, John Waldron, John Kim, Laura A Dawson, Andrew Bayley, Andrew Hope, Brian O'Sullivan.   

Abstract

PURPOSE: The role of primary radiotherapy (RT) for laryngeal verrucous carcinoma (LVC) is controversial because of concerns about anaplastic transformation, an increased incidence of metastases, and poorer local control after RT. To address these concerns, we report our experience. METHODS AND MATERIALS: All patients with pathologically diagnosed LVC treated with primary RT at our institution between 1961 and 2004 were reviewed. The local control, overall survival, and disease-specific survival rate were established. The outcome after salvage treatment and the incidence of metastases and anaplastic transformation were determined.
RESULTS: Of 62 LVC patients with a minimal follow-up of 2 years, 20 local and 1 nodal recurrence were identified. Salvage surgery was undertaken in 18 of the 21 patients, and disease control was achieved in 17; the eighteenth patient died of a complication after surgery. Ultimate laryngeal preservation was achieved in 50 patients (81%), including 42 after initial RT and an additional 8 after salvage surgery. Distant failure and anaplastic transformation were not observed. Second cancers after RT were identified in 4 patients, only 1 of which was a head-and-neck cancer detected 11 years later. Of the 39 deceased patients, only 3 died of LVC. The local control, overall survival, and disease-specific survival rate at 5 years was 66% (95% confidence interval, 52-77%), 87% (95% confidence interval, 75-93%), and 97% (95% confidence interval, 87-99%), respectively.
CONCLUSION: The results of our study have shown that the initial control of LVC with RT is less reliable compared with reports from surgical series; however, local recurrence was almost always salvaged successfully, resulting in disease-specific survival rates equivalent to those of surgical series. Neither anaplastic transformation nor unusual metastasis development was observed in this series.

Entities:  

Mesh:

Year:  2008        PMID: 18707828     DOI: 10.1016/j.ijrobp.2008.05.021

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Intraarterial chemotherapy: a valid option in the treatment of verrucous carcinoma?

Authors:  Primoz Strojan; Alfio Ferlito; Chih-Fung Wu; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06       Impact factor: 2.503

2.  Verrucous carcinoma (carcinoma cuniculatum) of the head and neck: what do we know now that we did not know a decade ago?

Authors:  Kenneth O Devaney; Alfio Ferlito; Alessandra Rinaldo; Adel K El-Naggar; Leon Barnes
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-01       Impact factor: 2.503

Review 3.  How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?

Authors:  Fernando López; Michelle D Williams; Antonio Cardesa; Jennifer L Hunt; Primož Strojan; Alessandra Rinaldo; Iain J Nixon; Juan P Rodrigo; Nabil F Saba; William M Mendenhall; Miquel Quer; Carlos Suárez; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-31       Impact factor: 2.503

4.  Definitive Radiotherapy versus Surgery for the Treatment of Verrucous Carcinoma of the Larynx: A National Cancer Database Study.

Authors:  Anvesh R Kompelli; Michael H Froehlich; Patrick F Morgan; Hong Li; Anand K Sharma; Cherie-Ann O Nathan; David M Neskey
Journal:  Int Arch Otorhinolaryngol       Date:  2021-11-03

Review 5.  Temporal bone verrucous carcinoma: outcomes and treatment controversy.

Authors:  Mia E Miller; Neil Martin; Guy F Juillard; Sunita Bhuta; Akira Ishiyama
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-26       Impact factor: 2.503

6.  Multiple synchronous verrucous carcinomas of the scalp in the background of generalized verruca vulgaris.

Authors:  Arvind Krishnamurthy; Vijayalakshmi Ramshankar; Thangaraj Viveka Soundara; Urmila Majhi
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

7.  An individual drug-therapy and genetic testing report of temporal bone verrucous carcinoma.

Authors:  Haolei Tan; Yong Liu; Gangcai Zhu; Leiming Pi; Donghai Huang; Xin Zhang
Journal:  Onco Targets Ther       Date:  2014-09-04       Impact factor: 4.147

8.  Oral Verrucous Carcinoma: Ten Year Experience from a Tertiary Care Hospital in India.

Authors:  Joshua Franklyn; Rajinikanth Janakiraman; Amit J Tirkey; Cecil Thankachan; John Muthusami
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.